KBB Of South Korea Prepares To Mass Produce Bone Regenerating Proteins
This article was originally published in PharmAsia News
Executive Summary
The Korea Bone Bank in South Korea says it is preparing to mass produce bone morphogenetic proteins while moving to complete clinical trials and obtain regulatory approval by the end of this year